drugset / Trial / NCT01572623

Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting

NCT01572623 ↗

Phase 4 Unknown 150 enrolled Campus-Bio-Medico University
RandomizedFactorialOpen-labelPrevention

Summary

The purpose of this study is to evaluate the efficacy and safety of two different loading doses of Clopidogrel and a reloading of Atorvastatin in the prevention of periprocedural ischemic brain damage in patients undergoing carotid angioplasty.

Timeline

Start
2011-07
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 40 mg —
Comparator Clopidogrel Small molecule 300 mg —
Comparator Clopidogrel Small molecule 600 mg —

Indications